Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
ORBIMED ADVISORS LLC TELA TELA Bio, Inc. 13D/A 9.9% 2y
Apex Holdco L.P. VERY Vericity, Inc. Common Stock 13D/A 0% 2y
Ara K. Hovnanian HOV Hovnanian Enterprises Inc 13D/A 15.2% 2y
GKCC, LLC ELTX Elicio Therapeutics, Inc. 13D/A 19.99% 2y
Headlands Capital Management, LLC NDLS NOODLES & Co 13D/A 9.5% 2y
Deutsche Telekom AG TMUS T-Mobile US, Inc. 13D/A 57% 2y
Pinetree Capital Ltd. TBRG TruBridge, Inc. 13D/A 10.8% 2y
Keith A. Hutton TXO TXO Partners, L.P. 13D 10.4% 2y
DGP Co., Ltd. XCUR Exicure, Inc. 13D/A 35.4% 2y
A. Lorne Weil INSE Inspired Entertainment, Inc. 13D/A 9.9% 2y
Hawk Acquisition, Inc. INVE INVE Technologies, Inc. 13D/A 0% 2y
CAS Investment Partners, LLC CDLX Cardlytics, Inc. 13D/A 13.2% 2y
Joe Lewis INSG Inseego Corp. 13D/A 16.7% 2y
Divisadero Street Capital Management, LP DAVE Dave Inc. 13G 5.9% 2y
Robert Forster CNSP CNS Pharmaceuticals, Inc. 13G 0% 2y
Deep Track Capital, LP CLYM Climb Bio, Inc. 13G 5.85% 2y
ROGER M. KLEIN AGRX Agile Therapeutics, Inc 13G 9% 2y
Millennium Management LLC ZIMV ZimVie Inc. Common Stock 13G 4.7% 2y
F. Hurst Lin (“Lin”) GCT GigaCloud Technology Inc 13D/A 13.8% 2y
Alumni Capital LP KZIA Kazia Therapeutics Ltd 13G 9.99% 2y
Decus Pro OU FCCN SPECTRAL CAPITAL Corp 13D 41.83% 2y
Leonard M. Tannenbaum AFCG Advanced Flower Capital Inc. 13D/A 27.5% 2y
Liang Meng HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13D/A 13.7% 2y
Advent International, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 22.4% 2y
Louis A. DeNaples FNCB FNCB Bancorp Inc. Common Stock 13D/A 0% 2y
CoyCo GP, L.L.C. RCM R1 RCM Inc. Common Stock 13D/A 32.3% 2y
OH Cypress Aggregator, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 4.5% 2y
GAMCO INVESTORS, INC. ET AL CUTR Cutera, Inc. 13D/A 2.48% 2y
Legion Partners Asset Management, LLC LFCR Lifecore Biomedical, Inc. De 13D/A 15.2% 2y
22NW Fund, LP LFCR Lifecore Biomedical, Inc. De 13D/A 12.4% 2y
Irrevocable Larson Family Investment Trust RMTI Rockwell Medical, Inc. 13G/A 8.5% 2y
RA CAPITAL MANAGEMENT, L.P. CLYM Climb Bio, Inc. 13D/A 47.1% 2y
Mitsui Sumitomo Insurance Co Ltd HIPO Hippo Holdings Inc. 13D/A 4.46% 2y
Ernest C. Garcia II CVNA Carvana Co. 13D/A 41.1% 2y
MILLENNIUM MANAGEMENT LLC MED Medifast Inc 13G 4.3% 2y
LAWRENCE SANDS VSEE Vsee Health, Inc. 13D 25.96% 2y
IMOIGELE P. AISIKU VSEE Vsee Health, Inc. 13D 24.07% 2y
MILTON CHEN VSEE Vsee Health, Inc. 13D 19.53% 2y
Keith Gill CHWY Chewy, Inc. 13G 6.6% 2y
RA CAPITAL MANAGEMENT, L.P. PRAX Praxis Precision Medicines, Inc. 13G 7.2% 2y
EcoR1 Capital, LLC TECX Tectonic Therapeutic, Inc. 13G 5.8% 2y
Patrick E. Paddon Irrevocable Trust 2024 CFNB California First Leasing Corp 13G 14% 2y
Mr. G.V. Prasad N/A RDY Dr Reddys Laboratories Ltd 13D/A 13.04% 2y
Radcliffe Capital Management, L.P. CPTKW Crown PropTech Acquisitions 13G/A 0% 2y
Ionic Ventures, LLC BBLG Bone Biologics Corp 13G/A 3.8% 2y
Radcliffe Capital Management, L.P. VMCAF Valuence Merger Corp. I 13G/A 0% 2y
Radcliffe Capital Management, L.P. CDAQF Compass Digital Acquisition Corp. 13G/A 0% 2y
Radcliffe Capital Management, L.P. ANGX Angel Studios, Inc. 13G/A 0% 2y
Radcliffe Capital Management, L.P. TWOA two 13G/A 0% 2y
Ionic Ventures, LLC GROM Grom Social Enterprises Inc. Common Stock 13G/A 1.8% 2y